Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.
about
Current status of vaccines for schistosomiasisAltered patterns of gene expression underlying the enhanced immunogenicity of radiation-attenuated schistosomesAn immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasA Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdensUse of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.Characterization and vaccination of two novel Schistosoma japonicum genes screened from a cercaria cDNA library.Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels.Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.A Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model.Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.Radiation-attenuated schistosome vaccination--a brief historical perspective.Vaccines and diagnostics for zoonotic schistosomiasis japonica.Back to the future for antiparasite vaccines?
P2860
Q24657733-B7E2B344-360E-4DA8-8B2A-3A90F8CE9546Q28472759-D73AF938-F3D5-43BF-80FE-8057FABC8BEEQ28541675-0960A4CC-A3A8-4316-8186-3C46AD233C9EQ33440001-193C18F3-357F-4A03-B07F-3FE313842D52Q33684408-4EC4C324-973F-46D0-A59E-D835B83CB5ECQ33955583-7D63CC0E-9C94-4912-84E5-F0B16A43A9DFQ34071134-2AB5A1FD-1D8F-40CA-8192-487D9FA73136Q34697676-C9D519F1-11A3-4A69-8AA8-B328FAF1E03DQ35000247-EC39070E-5F26-409D-B963-5D0B1BED342FQ35128551-4CE7C574-D670-40DE-97AF-98F42DE6274CQ35665650-A3677E4B-5D83-4B8E-9CEC-904F6FB194F1Q37425288-1E58690B-AAC8-4735-8DCE-5F9C692921ABQ38264085-1B8B7EF1-0895-4EE3-81AB-E3BE9D31D8B5Q46559450-72E44D81-758B-4747-82E2-D7137709970D
P2860
Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@ast
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@en
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@nl
type
label
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@ast
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@en
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@nl
prefLabel
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@ast
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@en
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@nl
P2093
P2860
P356
P1476
Previous or ongoing schistosom ...... e attenuated cercaria vaccine.
@en
P2093
André M Deelder
Dorcas S Yole
Govert J Van Dam
Idle O Farah
Patricia S Coulson
R Alan Wilson
Thomas M Kariuki
P2860
P304
P356
10.1128/IAI.01657-05
P407
P577
2006-07-01T00:00:00Z